The primary outcome measure of BETonMACE is simply to determine if there is a statistically significant difference between apabetalone and placebo groups for time to first occurrence of adjudication-confirmed narrowly defined MACE. There is no requirement to meet any arbitrary relative risk reduction mark in order to claim success in meeting the primary outcome.
Time machine set for approximately 15 days ago. Engage!